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A quinquennium of CAPD at the Johannesburg Hospital. K. I. Furman
and D. J. Cook. Renal Unit, Department of Medicine, University of the
Witwatersrand, Johannesburg, South Africa. From January 1979 to
December 1983 a total of 161 patients aged 6 to 74 years (mean, 46.6
years) were treated by CAPD for periods that ranged from 3 to 49
months. Six patients were maintained on CAPD for longer than 3 years
and one of these had continued for more than 4 years. Sixty (37.5%)
patients were transferred to hemodialysis (HD) within 12 months of
starting treatment; of these, 32 patients were only intended to be held
temporarily on CAPD pending a vacancy on the HD program. Also
within 12 months of commencing CAPD, 12 patients were transplanted
directly. Treatment was discontinued in four patients because of
recovery of adequate renal function. The mortality rate was greater in
these CAPD patients in the initial than in subsequent years on treat-
ment. Unremitting peritonitis was the major complication necessitating
transfer to HD. Other reasons were inadequate dialysis and ultrafiltra-
tion. Temporary HD was used to tide patients over short periods when
catheters were removed to treat peritonitis, catheter tract, and exit site
infections. A variety of abdominal hernia manifested in 14 patients
during the course of CAPD. These were repaired surgically in eight
patients without interruption of CAPD and in two with temporary HD.
Continual improvement of facilities, equipment, and technique was
accompanied by corresponding escalation in expenditure. The total cost
of maintaining the CAPD unit during 1983 with a floating population of
38 to 45 patients is estimated to have been in the region of one million
Rands.
Peritoneal fluid pH changes during peritonitis in patients on CAPD. R.
van Zyl-Smit. Department of Medicine, University of Cape Town and
Renal Unit Groote Schuur Hospital, Cape Town, South Africa. Patients
with spontaneous bacterial peritonitis have recently been shown to
have a consistent drop in the pH of their ascitic fluid. A study was done
oh patients on peritoneal dialysis to determine the value of pH deter-
mination of dialysis fluid in the diagnosis and management of
peritonitis. After each 2-hr dwell period a sample of peritoneal fluid was
taken for pH determination. This measurement was done with 60 sec of
removal of the fluid from the dialysis bag to prevent a drift of pH due to
equilibration of carbon dioxide with air. Dialysate has a pH of 5.35
which rapidly equilibrates with body pH (mean 7.49; SD = 0.12; N =
130). Peritonitis caused a mean drop in pH to 7.33 (SD = 0.15; N = 48).
This difference is significant (P < 0.01). Staphylococcus epidermidis
caused a relatively small drop in pH, mean 7.40, (SD 0.05), Staphylococ-
cus aureus a mean drop to 7.32, (SD 0.13) while gram-negative
organisms caused a much more profound drop, mean pH 7.12 (SD =
0.11). The presence of a systemic acidosis also resulted in a lowering of
the pH but did not necessarily correlate with the nature of the offending
organism. In conclusion, pH determination is a quick, easy, and cheap
test which could aid in the early choice of an appropriate antibiotic for
patients with peritonitis on CAPD.
Complications of continuous ambulatory peritoneal dialysis (CAPD)—
a 4.5-year experience. I. Parsoo, V. K. Seedat, S. Naicker, and J. C.
Kallmeyer. Renal Unit, Addington Hospital and Department of Medi-
cine, University of Natal, Durban, South Africa. During a 4.5 year
period 107 patients (60 males and 47 females) were treated by CAPD.
The duration of therapy ranged from 1 month to 50.4 months (mean,
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12.2 months) giving a total experience of 109 patient years. Peritonitis
was experienced 277 times, that is, one episode every 4.7 patient
month. Thirty percent of the episodes of peritonitis were due to
Staphylococcus aureus. Staphylococcus epidermidis (20.5%), acineto-
bacter (7.2%), and pseudomonas (6.6%) were the other major or-
ganisms isolated. The catheter was sterile in 25.6% of cases. Other
important complications included skin exit site infection (51%), outer
cuff extrusion (20.5%), fluid overload (18.6%) and obesity (9.3%).
Intestinal obstruction due to adhesions occurred in 2.8% and gross
intra-abdominal adhesions which made further CAPD impossible oc-
curred in 9.3%. No cases of incisional hernia has yet been seen. Severe
peritonitis remains the major cause for hospital admissions to this unit.
It was responsible for catheter loss in 20.5% and abandonment of
therapy in a further 12% of patients. Peritonitis must represent the
single most important limiting factor to consider CAPD as an alternative
to haemodialysis for the long-term treatment of patients with endstage
renal disease. Peritoneal sclerosis may present a major problem in the
future.
Dialysis kinetics—Preliminary study using single pool model. M. D.
Pascoe, W. van Dalen, and M. Abrahams. Department ofMedicine,
University of Cape Town and Renal Unit, Groote Schuur Hospital,
Cape Town, South Africa. This study was aimed at assessing the
usefulness of a single pool hemodialysis model in determining the
adequacy of dialysis and in evaluating the dietary protein intake.
Thirty-four stable chronic hemodialysis patients were studied. Blood
samples were obtained from the dialysis "A" line at the end of the first
dialysis of the week and at the beginning and end of the second dialysis
of the week for blood urea determinations. A dietary history was
obtained by the unit dietician for assessment of protein intake. The
generation rate (Gu) and volume of distribution of urea (Vu) and the
protein catabolic rate (PCR) were calculated using a programmable
calculator and published formulas. The calculated PCR did not cor-
relate with the dietary protein intake (r = 0.127). The PCR correlated
with the Gu/kg total body weight (r = 0.728). The mean total body
water in these patients was 60% of the total body weight. The
correlation between body weight was however weak (r = 0.58). A plot
of PCR (G/kg) against pre-dialysis mid-week urea identified those
patients who were over and under dialyzed and those taking excess
dietary protein, enabling changes in dialysis schedules to be made.
Single pool hemodialysis modeling provides a guide to both the amount
of dialysis each individual patient needs and to the patient's nutritional
state.
Two-compartment analysis of hemodialysis data. L. C. Isaacson, L. de
Rooy, and M. Pascoe. Department of Physiology, Medical School,
University of Cape Town, Cape Town, South Africa. We have explored
the validity of a 2-compartment analysis of urea (u) and creatinine (cr)
kinetics during and after hemodialysis. In 16 patients, plasma u and cr
were measured before and three times during dialysis, and 3, 24, and 48
hr later. Body weight (BW), ultrafiltration coefficient (QF), and dialyser
and renal clearances (KD, KR) were also measured. Analysis was
attempted (A) by assuming ICF and ECF volumes 40 and 20% of BW,
and (B) by an iterative technique yielding best-fit values for KD, mass
transfer coefficient (MT) and ICF and ECF volumes. Overall, KDu was
153 30, KDcr 119 27, and QF 6.4 1.8 mI/mm. In the seven
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non-anuric patients, KRu 1.11 0.55, KRcr 1.60 0.94 mI/mm. After
10-mm of dialysis, u fell to 83 12%, cr to 80 15% of the predialysis
concentration. (r = 0.62); in three subjects, cr fell to 50 to 55%; in I, u
fell to 45%. At 3 hr postdialysis, u = 173 77%, cr 133 20%, of the
end-dialysis concentration. Analysis (A): MTu = 522 197; MTcr =
319 484 ml/min; urea generation rate (Gu) = 138 57, Gcr = 5.3
3.0 iimoles/min. Analysis (B): MTu 453 240, MTcr 274 298 mI/mm;
Gu 131 65, Gcr 6.0 2.5 moles/min; ICF 41 41 6, ECF 15
7%. The urea pooi size, assuming a single pool, was 48 9% BW:
assuming two pools, 56 9% BW (r = 0.49). The data are inconsistent
with simple two-pool kinetics for either urea or creatinine.
The significance of chronic endotoxemia (CE) in regular hemodialysis
patients (RHP). A. M. Meyers, M. P. A. Lessing, H. J. van Wyk, and H.
Stroucken. Division of Nephrology, Department of Medicine, Uni-
versity of the Witwatersrand, Johannesburg, South Africa. The oc-
casional presence of endotoxins (E) in dialysate (d) is well known. The
genesis, clinical and immunological significance of serum E (SE) in
RHP has been studied infrequently and forms the basis of this report. E
and SE were measured by the Limulus Amoebocyte Lysate test in
tapwater (t), dialysate in and dialysate out, blood (b) on three occasions
in 30 RHP pre and post dialysis and controls: CI = 8 normals, CII = 16
stable uremics, CIII 13 CAPD patients. Type of artificial kidney
(AK) was recorded. E levels were measured (d and b) in eight sham
dialyses (SD) using sterile H20 for blood and dialysate; AK = 2 x
Gambro (G), CDAK(C), Triex(T), and HFD(H). All E and SE were
expressed in pg/mi; t = 80 — 120; CI = 105 33; CII = 39 + 17; CIII
= 39 + 17; CIII = 121 37. Mean di = 1031 + 88, do = 967 163:
P < 0.025. Mean pre and post blood in = 533 386 vs. 701 523: P
<0.005. SE levels in patients on G or C significantly less than T or H;
X2 = 20.25, P < 0.001 confirmed by SD. SD:blood in and blood out.
Max E = 47 for G and C and <600 for T and H confirmed: dialysate in
= 0 — 14, dialysate out = 44 to 273 pg/mi. Patients with chronic SE>
400 were more presensitized to the panel of 24 lymphocyte donors than
those with < 400 (X2 = 6.86, P < 0.01). Thus E from deionized water
as well as from some AKs result in CE and may contribute to the cause
of significant presensitization in MHP. Other clinical parameters are
being studied, for example, drop in P02, splenomegaly, and hepatitis.
The problem is more than an epiphenomenon and may be of enormous
importance in RHP.
Physical properties of the red cell in chronic renal failure. M. Viljoen,
F. J. Mi/ne, andA. A. de Oliveira. Departments of General Physiology
and Medicine, University of the Witwatersrand, Johannesburg, South
Africa. Reports on the physical characteristics of the red cell in chronic
renal failure (CRF) patients on maintenance hemodialysis (MHD) are
few and often contradictory. It is further not possible to predict the
physical characteristics from the biochemical characteristics because of
the presence both of factors which are known to improve physical
properties, and of factors known to impede it. Physical properties such
as osmotic fragility (OF), ultrasonic fragility (UF), H202 fragility
(H202F), H202 fragility in the presence of glucose (H202 F Glu), time-
dependent fragility (TF), spreading index (SI), filtration index (Fl), %
plasma trapping (% PT) and hematograms were investigated. Four
groups of subjects were studied: a stable CRF group on MHD (group I,
N = 24), a hemolysing CRF group on MHD (group 2, N = 13), a
control CRF group on conservative treatment (group 3, N = 22) and a
control group of normal healthy volunteers (group 4, N = 22). The
results indicate that: (a) abnormal physical characteristics do indeed
contribute to the anemia of CRF on MHD; (b) the extent to which they
contribute is modified by treatment, the purity of the dialysis water, and
other physiological abnormalities superimposed on the anephric state;
(c) abnormalities are to an extent masked by the young cell age; (d) cells
from CRF on MHD are exceptionally prone to physical change.
Vitamin E levels and an abnormality in the hexose monophosphate
shunt (HMPS) in CHD patients with chioramine-induced hemolysis. J.
Cohen, M. Viljoen, D. Clifford, Y. Veriava, and F. J. Mi/ne. Depart-
ments of Medicine and General Physiology, University of
Witwatersrand, Johannesburg, South Africa. CHD patients with
chloramine-induced hemolysis are thought to have abnormalities of the
HMPS. We undertook an assessment of serum vitamin E levels, an
antioxidant substance, in a group of CHD patients exposed to high
levels of chloramine in the dialysis water. Serum vitamin E levels were
measured in the affected group (N = 15) and compared to normal
controls (N= 17) and a CHD population not exposed to high chloramine
levels (N = 19). The mean vitamin E level in the affected group was 4.9
mg/liter (SD 2.6), normal controls 8.9 mg/liter (SD 1.9) and CHD
patients exposed to low chloramine 9.6 mg/liter (SD 3.7). The
difference between the affected group and each of the other two groups
was statistically significant (P < 0.001). Within the affected group,
hemolysis was confirmed by the finding of elevated reticulocyte counts,
raised postdialysis methemoglobin values, and the presence of Heinz
bodies. G6PD values were normal in this group. The ascorbate cyanide
test was used as a screening test of the HMPS pathway in this group.
Those patients exhibiting an abnormal test (N = 10) had a mean vitamin
E level of 3.88 mg/liter (SD 1.84) compared to a level of 7.0 mg/liter
(SD 2.58) in those with a normal test (N = 5) (P < 0.05). After
removal of chioramine from the feed water, the mean vitamin E level in
the affected group has risen to 7.9 mg/liter (SD 2.1). These results
suggest an increased consumption of vitamin E in patients with
chloramine-induced hemolysis and HMPS abnormalities.
Renal red cells: Are Na/K abnormalities due to natriuretic factor or
membrane defects? F. J. Mi/ne, J. da Si/va, L. Laidley, J. Cohen, and
M. Viljoen. Departments of Medicine and General Physiology, Uni-
versity of the Witwatersrand, Johannesburg, South Africa. Many
believe that the plasma of renal failure patients inhibits the ouabain-
dependent Na K ATPase pump resulting in high intracellular Na
concentrations. Others have found red cell (RBC) membrane ab-
normalities, suggesting a young population of cells (RBC Na should be
low). We studied 18 controls (C), who were matched with ten chronic
hemodialysis (CHD) and ten chronic renal failure patients (CRF).
Plasma and RBC Na and K were measured before and after
incubation with 50 and 200 l 0.1 mM/liter ouabain. Cross-incubation
experiments between both the RBC and plasma of C and CHD were
performed after the addition of 50 iii ouabain. RBC ATP and ADP
levels were measured by high pressure liquid chromatography. The
RBC ATP and ADP levels were significantly higher (P < 0.05) in CHD
(1.5 0.08: 0.38 0.13 mmoles/liter) compared to C (0.85 0.14; 0.28
0.07). The basal RBC Na was strikingly lower in both renal groups
(CHD 5.4 mmoles/iiter 1.0 (SD); CRF 5.3 1.7; C 7.4 1.8), while
the RBC K was the same. The ouabain dose response curves were
significantly flatter (P < 0.05) for plasma Na and K in both renal
groups. The RBC Na response to ouabain was significantly flatter in
absolute, but not percentage terms, in the renal groups. The addition of
CHD plasma to C RBC significantly blunted the RBC Na change after
incubation with ouabain, while similar incubation of C plasma with
CHD RBC increased the RBC Na response but not to C levels. The
changes in RBC K paralleled Nat. The flattened ouabain dose
response curves and the cross incubation experiments would support a
circulating natriuretic factor. However, the higher RBC ATP and ADP
levels, the low RBC Na concentrations, and the partial cross incuba-
tion responses suggest a RBC membrane defect. Thus, renal patients
seem to have both abnormalities.
Bone histomorphometry in the diagnosis and treatment of renal
osteodystrophy. S. Teitelbaum. Department of Pathology, Jewish Hos-
pital at Washington University Medical Center, St. Louis, Missouri,
USA. Renal osteodystrophy is a generic term comprising the host of
metabolic and morphological derangements of bone which attend renal
failure. The morphological manifestations of uremic osteodystrophy
include combinations of hyperparathyroid bone disease and
osteomalacia in a setting of reduced normal or increased bone mass.
Because renal osteodystrophy is a metabolic bone disease, the common
element of which is diffuse skeletal involvement, the histological
features of bone at any site may be extrapolated to the skeleton at large.
This realization makes the random ("blind") biopsy central to the study
of these disorders. The importance of the bone biopsy in the manage-
ment of metabolic bone disease reflects two major technical achieve-
ments. The first is the capacity to obtain well preserved samples of bone
by relatively atraumatic means, and second, is the development of
techniques by which non-decalcified histological sections of bone may
be prepared. These sections are essential to the diagnosis of specific
forms of renal bone disease because unlike decalcified material, they
permit easy distinction of mineralized from non-mineralized bone
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matrix (osteoid) and consequently, identification of those patients with
excess osteoid. These techniques, coupled with the use of tetracyclines
as kinetic markers of bone mineralization, permit the precise definition
of the various forms of renal osteodystrophy and have led to rational
and successful therapeutic programs. For example, although it is now
well known that aluminum intoxication is the major contributor to the
development of renal osteomalacia, this information reflects demonstra-
tion of this cation in bone by histological techniques. Similarly, the use
of vitamin D and its metabolites in the treatment of particular forms of
uremic bone disease has been established by histological data. Because
virtually all patients with chronic renal failure have some degree of
renal osteodystrophy, an understanding of bone histology as a diagnos-
tic tool is essential to all physicians involved in the care of such
individuals.
Thallium technicium subtraction scintiscanning (TTSS) and hyper-
parathyroidism (HTP)—A preliminary study. H. Panayiotou, J. Esser,
A. M. Meyers, J. R. Botha, D. Ninin, and J. Levin. Division of
Nephrology, Departments of Medicine, Nuclear Medicine and Surgery,
University of the Witwatersrand, Johannesburg, South Africa. TTSS
has been recently added to the list of non-invasive techniques for
investigating HPT. The aims of this study are to assess this technique
with respect to preoperative parathyroid gland localization, differentia-
tion between adenoma and hyperplasia, the value in diagnosing the
difficult case, e.g., recurrent HPT or biochemical uncertainty and
finally, as a diagnostic tool in its own right. Thirty-six patients with
probable HPT had TTSS. This report analyzes the results of 8 females
and 7 males aged 20 to 72 years (mean 49), who have already undergone
parathyroid surgery; 4 of the 15 had HPT secondary to chronic renal
failure (CRF). There were 14 white patients and 1 black patient. Six
patients presented with overt bone disease, six with renal stones, one
had pancreatitis, and two were asymptomatic. Mean serum calcium was
2.88 (2.6 to 3.36) in primary (1°) HPT and 2.52 (2.42 — 2.8) mmoles/liter
in secondary (2°) HPT. Mean Cl/P04 ratio was 145 (99 to 257) in 10 HPT
and 53 in 2° HPT. Mean PTH levels 2.2 ng/liter for 1° HPT and 8.6
ng/liter in 2° HPT. Mean serum alkaline phosphatase was 617 in a
patient with bone disease and 101 in a patient without bone disease. At
operation 7 adenomas were found, 1 patient had double adenoma, 8
patients had hyperplasia and nothing was found in I. There was scan
and operative correlation in 10 of 15 patients (67% accuracy), 3 of the 7
adenomas were correctly located (43% accuracy) and 4 were missed
(57% false — ye rate). There were three false positives, one due to
thyroid remnant, one large hyperplastic gland and one adenoma was
wrongly located, reason not obvious. This procedure is recommended
in the pre-operative differentiation between adenoma and hyperplasia in
HPT and localization of any adenomas. Normal controls require to be
studied as none have been reported in previous literature.
The anemia of chronic renal failure: Is there an association with
secondary hyperparathyroidism? M. J. D. Cassidy, H. A. Ellis, J.
Dewar, J. R. Farndon, M. K. Ward, andD. N. S. Kerr. Department of
Medicine, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne,
England. In this retrospective analysis of 22 patients undergoing
parathyroidectomy for secondary hyperparathyroidism, while on dial-
ysis, there was no significant difference in the mean hemoglobin 1 year
before and 1 year after the operation (7.5 g/dl SD 1.7 vs. 8.0 g/dl SD
1.5). There was a reduction in requirements for blood transfusion
(BT) in the year following the operation in the majority of patients.
Mean BT requirements I year pre-operation were 5 U. Mean BT 1 year
postoperation was 2.5 U (P = < 0.001). In ten patients who had
trans-iliac bone biopsies 6 months or less before parathyroidectomy,
there was a significant correlation between the severity of anemia and
marrow fibrosis (r 0.78, P = < 0.01). In 9 out of 10 patients, in spite
of the anemia the marrow was still comprised of a relatively high
proportion of fatty tissue (up to 89.9%). These findings are consistent
with, though not proof of, a myelophthisic cause of the anemia
associated with hyperparathyroidism. We suggest that the bone marrow
of patients with chronic renal failure and secondary hyperpara-
thyroidism is less able to respond to anemia and that there may be a
factor present in these patients inhibiting the normal myeloproliferative
response to anemia.
The evaluation of multistix SG in clinical practice. G. R. Keeton, J.
Bruss, and D. Arendsen. University of Cape Town, Department of
Medical Renal Unit, Cape Town, South Africa. The ability to ac-
curately define specific gravity (SG) on a small volume of urine with
multistix (MS) is tested in this study against a refractometer (TSM),
urinometer (U), and the calculated osmolality of urine (COU). A
hundred urine specimens from randomly selected patients were evalu-
ated. The findings were recorded, that is, the full MS data and readings
of TSM and U. The concentration of urea, Na, K, creatinine, glucose,
protein, and pH was measured on all specimens. On 34 specimens a
difference was observed of MS SG and in 56% of these it occurred in the
1010 to 1020 range. Only two specimens differed significantly on TSM
and U. On 43 specimens MS differed from TSM and COU [2(Na + K)
+ urea]. Nineteen were in the range of 1010 to 1020 with 12 reading
lower (MSL) and 8 higher (MSH) than TSM.
Urea
SGI
MS
SGI
TSM COU Na K
+
Gluc pH
MSL(N = 8) 1012 1028 721 159 44 314 6.8
MSH
(N = 11) 1023 1013 487 71 48 248 5.18
Results are expressed as means; Na, K, urea—mmoles/liter.
The mean COU (table) matched best with the TSM readings and poorly
with MS. The use of a correction factor for high urine pH improved the
correlation of MS with TSM in the MSL group. In the MSH group there
is poor correlation between the MS and TSM and calculated osmoles;
there is also a low Na:urea ratio and lower mean pH (5, 18). There is a
significant observer error in the important range of SG from 1010 to
1020 with the use of MS. The correction for pH improves false low
readings. The false high readings (11%) are associated with a low
Na:urea ratio and a low pH. A significant observer error in the use of
MS SG and the unreliability at low pH seriously limit its usefulness.
The prevalence and survival of toxic nephropathies during two study
periods, 1976 to 1978 and 1980 to 1982 at the H. F. Verwoerd Hospital.
C. D. Potgieter, A. Shaw, A. van der Hoven, and J. van der Merwe,
Department of Medicine, University of Pretoria, Pretoria, South Af-
rica. The aim of this study was to look at the prevalence and survival of
acute renal failure due to toxic nephropathies during 1976 to 1978 and
again from 1980 to 1982. Previous renal disease was excluded as far as
possible in all cases. The prevalence was 28.7% during 1976 to 1978 and
the survival rate over the same period was 25.7%. In the second study
period, 1980 to 1982 the prevalence of acute renal failure due to toxic
nephropathies increased to 42.42% of all acute renal failures. The
survival rate of patients during 1980 to 1982 also increased to 92.8%. In
conclusion, there was an increase in acute renal failure due to toxins
and also an increased survival rate during 1980 to 1982. The toxins that
were mainly involved were aminoglycocides, metoxyflurane,
carbontetrachloride, and analgesics. Toxin-related acute renal failure
has increased mainly due to the increased use of aminoglycosides. The
increased survival rate of the patients during 1980 to 1982 was probably
due to better treatment facilities, earlier recognition, changes in treat-
ment policies and patient care. In all cases of acute renal failure toxins
should be considered and once recognized recovery from renal failure is
always possible and treatment regimens should keep this in mind.
Acute renal failure following abdominal aneurysmectomy. C. S.
Hesdorffer, F. J. Mime, C. Clinton, P. Becker, B. Beiles, and A. M.
Meyers. Department of Medicine, University of the Wiiwatersrand and
Johannesburg Hospital, Johannesburg, South Africa. We performed a
retrospective analysis of patients undergoing abdominal aneurysm
repair. The aim of the study was to determine the factors which should
be considered perioperatively in predicting the development of renal
failure. Two groups of patients were compared in a case control study.
The first consisted of 29 patients who developed renal failure, 14 of
whom required dialysis, while the other 15 responded to conservative
treatment. The other group comprised 58 (selected from 80) patients
who did not require dialysis. Chi-square analyses were performed on
the variables considered. Mortality was 62% in the group in which renal
failure developed, as opposed to 16% in the second group. Of the
898 Abstracts
patients requiring dialysis, 12 of 14 died. Four factors were significant in
predicting the development of renal failure: (1) a past history of
hypertension, (2) a hypotensive episode occurring perioperatively, (3)
emergency procedure for rupture, and (4) females seemingly more
prone. Other factors previously reported as being important such as
age, site of the aneurysm, and preoperative renal dysfunction we found
to be of no relevance. These findings suggest that we should change our
policy toward abdominal aneurysm surgery, enabling us to anticipate
renal failure, and thus a poorer prognosis, in a select group of patients,
who can then be more critically evaluated with regard to the allocation
of scarce resources, and the application of renal protective procedures.
Laxative abuse (LA) and (autonomous) pseudo-Bartter syndrome
(PBS)—A clinico-pathological study. A. M. Meyers, H. Panayiotou, D.
Ninin, L. Feldman, and M. I. Sonnekus. Division of Nephrology,
Departments of Medicine and Pathology, University of the
Witwatersrand, Johannesburg, South Africa. LA is a common form of
bulimia producing well known electrolyte disorders. Several serious
less well appreciated or new metabolic aberrations form the basis of this
report. Seven patients were studied clinically, biochemically and three
had renal biopsies repeated 1 year later. Using anti-PGE2 antibody and
immunofluorescence, the biopsy specimens were assessed for PGE2.
All seven were females, mean age 34 years, weight 41 kg, petite, well
groomed, and were followed 3 to 84 months (27.8). Seven presented
with weakness or paralysis, six polyuria, and UTI, four cramps and
myalgia, two coma, one fits, and three abused analgesics and one
alcohol. On laxative withdrawal, five had edema, two CCF and one had
an epileptic convulsion. All results were expressed as means in SI units.
Urea 19, Cr 245, K 2.2 before and 4.2, 136, and 4.1 after treatment.
Admission uric acid 0.27 mmoles/liter and was less than 0.25 in 4.
Hypo-K in 7, hypo-Ca and Mg in 5, hypo Pi in 4. PTH low in 3, raised
in 1. Direct correlation was found between Ca and Mg, r = 0.78, P <
0.01. Cr.Phosphokinase elevated in 5 and CKMB in 2; myoglobulinuria
in 3. Inverse correlation between Ca and Pi, r = 0.63, P < 0.05; no
correlation CPK vs K. PRA and AId. raised in three of three for up to
18 days. Plasma volume was normal in one and low normal in two; urine
PGE2:F2cs 1.1, 1.7, and 3.2 in matched controls vs 2.8, 8.3, and 8.7 in
three tested. These three had raised urine chlorides (112 to 191
mmoles/day). Biopsy specimens revealed JGA and marked medullary
interstitial hyperplasia (MIH); —ye for PGE2. MIH was still present 1
year later in spite of LA withdrawal. Thus, LA results in profound hypo
K, Ca, Mg, Pi and uricemia with rhabdomyolysis, rebound hyper-
reninemia, and CCF. Autonomous PBs, that is, persistent defects even
after withdrawal of all agents, was suggested in two of three tested, the
exact nature of which requires further study. A name Metabolic
Madness" has been coined and pathogenetic mechanisms postulated.
Infantile polycystic kidney disease (IPKD). P. D. Thomson and J. M.
Isdale, Department of Paediatrics, University Witwatersrand, Johan-
nesburg Hospital, Johannesburg, South Africa. Between 1970 and 1983
we treated 30 children with IPKD (26 were from Afrikaner families).
The age of diagnosis ranged from 7 months gestation (ultrasound
diagnosis) to 3.5 years. Ten of 18 presenting at < I week died; whereas
11 of 12 presenting at > 1 week have survived. Early presentation was
invariably mass-related, whereas in late presenters the abdominal
masses were usually incidental findings. The 19 survivors have been
followed for 1.5 to 14 years. Those diagnosed at < 1 week (mean
follow-up, 6.3 years) had a mean creatinine clearance of 39 ml/min/l .73
m2 (range, 11 to 59). Those presenting at> 1 week (mean follow-up, 9.5
years) had a mean creatinine clearance of 30 mI/mm/I .73 m2 (range, 6 to
69); however, the difference for creatinine clearance with diagnosis at <
I week versus > I week was not significant. Eighteen of the 19
survivors have been hypertensive (HT), many requiring only low-dose
anti-HT therapy (usually those with decreased renal function and
greater FENa). Two patients no longer require anti-HT therapy (at 12
and 14 years, respectively). Thirteen have had splenomegaly, usually
detected after 4 years (range, 6 weeks to 10 years) and generally
followed, but occasionally preceded, by signs of hyperspienism. One
child had a hematemesis, although varices were demonstrated in
another three. Two patients were transplanted subsequent to bilateral
nephrectomy, splenectomy, and lieno-renal shunt (follow-up, 6 and 2.7
years, respectively). Liver function has been normal in all except for
increases in SGOT and/or SGPT in transplanted patients. IPKD survi-
vors of the neonatal period have a reasonable prognosis with supportive
therapy.
The use of donor-specific transfusions in renal transplantation at
Groote Schuur Hospital. C. R. Swanepoel, Y. Crombie, A. Pontin, J.
Jacobson, D. Taljaard, and R. van Zyl-Smit. Department of Medicine,
University ofCape Town and Renal Unit, Groote Schuur Hospital and
Provincial Laboratory for Tissue Immunology, Cape Town, South
Africa. We set out to determine the effect of transfusions, prior to renal
transplantation, on graft survival in non-identical live related opera-
tions. Two hundred milliliters of donor whole fresh blood were admin-
istered to the prospective recipient. This was repeated three times at
two weekly intervals. If tissue crossmatch was negative, transplanta-
tion took place 6 weeks later. Rhesus incompatibility was not an
exclusion factor. Imuran or Cyclosporin together with low-dose Medrol
was used. Nine donor/recipient pairs were in the DST program. The age
range of recipients was 11 to 37 years. Two were cancelled because of
development of antibodies in one and kidney artery anomaly in another.
Immediate graft function was established in six out of the seven
patients. Two patients had reversible rejection episodes within 4 weeks
of transplantation. The follow up period in the seven remaining patients
has ranged from 6 to 76 weeks (average, 27.5 weeks). Six of the seven
patients have normal serum biochemistry. Our limited experience and
overseas results suggest that DST is an important addition in the
management of patients with endstage renal failure.
Major pulmonary infections (P1) in the post-transplant (TP) patient. J.
Costa, A. L. Baptista, J. R. Botha, J. Seggie, J. Myburgh, and A.
Meyers. Departments of Medicine, Surgery & Cardiothoracic Surgery,
University of the Witwatersrand Medical School, Johannesburg, South
Africa. Sixty-two episodes of major pulmonary infection occurred in 56
patients over 17 years in which 547 renal transplants were performed in
483 patients. Fifty-four episodes followed 385 cadaveric TP (14%) and
8 followed 98 related living donor TP (8%). Fifteen died as a conse-
quence of PT and/or associated septicemia (24.1%). P1 occurred from 3
days to 4 years after 'UP but was predominant in the first 12 months (50
out of 62 episodes). The pathogenesis was as follows: Bacterial
agents—20 episodes (32.2%), non-identifiable organism—26 cases
(41.9%), other including viral and fungal agents—16 episodes (25.8%).
In six patients the infection was caused by two or more agents. The
most common presenting symptom was fever, followed by pleuritic
pain and respiratory distress. Sex, age, and primary renal pathology of
the infected patients did not influence the outcome nor was it signifi-
cantly different from the non-infected group of patients. Poor renal
function was significantly associated with the development of P1 and
acute deterioration of renal function occurred in 28 out of 62 episodes.
No significant difference was found in the number of rejection episodes,
prednisolone dosage, or blood glucose when comparing non-infected
with infected patients, although in seven a rejection episode was
coincident with PT. Leucopenia was present in 20 episodes and was not
associated with any specific pathogen. Splenectomy and bilateral
nephrectomy prior or at transplantation as well as blood grouping and
HLA typing, were not associated with an increased incidence of
pulmonary PT. Lung infections in renal TP patients were associated
with high mortality. Early diagnosis using methods as transtracheal
aspiration with gram stain and direct sensitivity plating leading to
specific treatment are essential for successful management and may
improve future results.
Malignancy in renal transplant recipients at the Johannesburg Hospi-
tal. L. P. Margolius, A. M. Meyers, J. R. Botha, J. Seggie, andf. A.
Myburgh. Departments of Medicine and Surgery, Johannesburg Hos-
pital, Johannesburg, South Africa. We assessed the incidence, out-
come, and possible etiological factors of malignancy in renal transplant
recipients at the Johannesburg Hospital. Between 1966 and 1983 a total
of 530 renal transplants were performed in 500 patients: 394 cadaver
(CD), 102 related (RLD), and 4 identical twin recipients. Records were
examined retrospectively and the incidence, spectrum of malignant
tumors, and relevant clinical parameters were determined. Age, sex,
source of graft, renal function, rejection episodes, duration of im-
munosuppression, and graft survival were compared in the group that
developed malignancy and the group that did not. Differences were
statistically evaluated using the unpaired t test, X2, and actuarial
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survival curves. Forty-four patients developed a total of 58 malignant
neoplasms, an incidence of 8.8%. The commonest was skin carcinoma
(Ca) which occurred in 44 ofSOO patients (8.8%). The differences in age:
38.8 years (Ca group) vs. 38.0 years (non-Ca group) and male/female
ratio: 24:1 (Ca group) vs. 44:1 (non-Ca group) were not statistically
significant. The differences in graft origin: 41 cadaver, 3 RLD (Ca group
and 353 cadaver, 99 RLD (non-Ca group) was significant (P < 0.01).
Renal function in those with Ca was significantly better than those
without (P < 0.001). Urea 9.9 5.9 mmoles/liter and Cr155 + 71.5jzmoles/liter in the former vs. 17.8 13.7 mmoles/liter and Cr.353
308.5 zmoles/liter in the latter. Those with Ca had had fewer rejection
episodes 1.95 1.6 than those without 2.25 1.4 (P < 0.001). Those
with Ca had had a longer duration of immunosuppression 71.6 39.7
months than those without 35.1 36.6 months (P <0.001). At all times
post-transplant the grafts of those who developed Ca survived better.
This is statistically significant. This suggests that those transplant
patients with malignancy have a significant degree of immune tolerance
with better graft survival, better graft function, and fewer rejection
episodes. Moreover, they have been immunosuppressed for longer.
Transplantation in an urban black population on weekly intermittent
peritoneal dialysis (IPD). M. P. G. Dean, G. Habicht, A. M. Meyers, J.
Seggie, and J. R. Botha. Division of Nephrology, Departments of
Medicine and Surgery, University of the Witwatersrand Medical
School, Johannesburg, South Africa. About 13 per million black
patients were on treatment for endstage renal disease in South Africa as
of December 1982, as compared to 167 white patients. Apart from
cultural, socio-economic and logistic factors in treating blacks with
ESRF, major problems which have been quoted are: difficulties in
procuring kidneys from black donors, the difficulty in locating patients
when suitable donors become available, and the mortality and rejection
rate in black recipients. To improve facilities and study these factors we
started a small IPD unit at the Hilibrow Hospital (max = 12 patients) in
July 1982. Patients with endstage renal failure younger than 50 years
and who lived in the area were accepted for 48 hr/week of IPD in
preparation for transplantation (RT). Thirty-two patients who met our
criteria for RT were dialyzed during 1983. All had at least one attack of
peritonitis (P). One developed miliary TB which was successfully
treated. Nine absconded and died at home (28%), two developed P
which necessitated transfer to a hemodialysis unit (9%), and one was
transferred to a unit in Natal (3%). Ten have received RT over the last
2 years, 7 in 1983. A system for donor calls improved contact of the
patients. No donor kidneys have come from the Hillbrow Hospital over
a 2-year period. Four patients received prednisone and imuran and six
low-dose prednisone and cyclosporin A. There has been one death and
no graft loss. No patient developed peritonitis post-operatively but one
developed TB. Actuarial graft and patient survival at 6 and 18 months
was 90%. All patients are fully rehabilitated. Although the numbers are
small and our experience limited, it would seem that despite many
problems IPD is a successful method of pretransplant dialysis. Black
subjects do as well, if not better, than their white counterparts afterRT.
The black urban community needs educating with respect to organ
donation.
Perfusion of isolated human renal tubules. L. C. Isaacson and C.
Swanepoel. Departments of Physiology and Medicine, University of
Cape Town, Medical School, Cape Town, South Africa. Relative to the
laboratory animal, little is known of renal tubular function in humans.
Accordingly, we have embarked on a long-term study of isolated and
perfused human renal tubules. Human tubules are sought in (a) kidneys
harvested but found unsuitable for transplantation, and (b) apparently
normal kidneys removed surgically. At surgery, the organ is perfused
with and then stored in, cold (4°C) EuroCollin's solution. Control
studies are performed on tubules obtained from rabbit kidneys, simi-
larly treated. Subsequent dissection, perfusion, and electrophysiologi-
cal investigation of isolated tubules use standard techniques. Tissue
viability is assessed by inspection during dissection, and then more
critically during perfusion by observation of cellular uptake of Trypan
Blue, of changes in transtubular electrical potential after warming to
37°C, and after exposure to antidiuretic hormone (ADH) and/or meta-
bolic inhibitors. Four rabbit tubules perfused after varying periods (hr)
of storage at 4°C revealed: (I) cortical collecting tubule (CCT) (28 hr);
—7 my; no response to ADI-I; potential abolished by dinitrophenol (2)
CCT (24 hr); +6 my; no uptake of Trypan Blue; ADH without effect (3)
thick ascending limb (24 hr); +3 my; abolished by gluteraldehyde; (4)
proximal convoluted tubule (24 hr), —1.8 my. Nine human kidneys
reached the laboratory 24 to 63 hr after harvesting. Dissection revealed
widespread tubular necrosis in 7; tubular dissection here was impos-
sible. From the remainder we obtained (I) CCT (24 hr); —16 my,
electrical response to ADH but no accompanying morphological
changes; (2) CCT (72 hr)—minimal Trypan Blue uptake—other studies
not done. To date, we conclude that (1) dissection of isolated renal
tubules in the normal human kidney is as easy as in the rabbit; (2) in
both the rabbit and humans tubular function can occasionally be
observed 24 to 72 hr after harvesting: (3) probably the majority of
human kidneys harvested for transplantation have widespread tubular
necrosis 37 to 63 hr later.
Renal function in maturity onset diabetes mellitus. A. Bryer, G. R.
Keeton, and M. Schneider-Waterberg. Renal Unit, Department of
Medicine, University of Cape Town, Cape Town, South Africa. The
present study evaluates deaths due to renal failure in maturity onset
diabetics (MODM) admitted to Groote Schuur Hospital (GSH); and
renal function in MODM attending a diabetic outpatient clinic (DOPC).
Over 3 years there were 105 admissions to GSH of MODM patients with
renal complications. There were ten deaths and in only three were these
uremic. In 338 DOPC attendances there were 62juvenile onset diabetics
(JODM) and 276 MODM. Thirteen percent of these MODM with
persistent proteinuria (Pr) were selected for study. Creatinine clearance
(Ccr) and Pr were measured; an assessment was made of the duration
(DUR) of diabetes, adequacy of control, drug therapy, hypertension(H), and vascular disease (VAS/D) including peripheral cerebral and
ischemic heart disease. Mean values are listed in the table.
N Age Years Cc, Pr H% VAS/D%
I. Total Group (TG) 44 59 10.8 61 2.461 50
2. Ins. Req. (IR) 20 58 13.3 73 1.8 55 50
3. Oral/diet (O/D) 24 59 8.7 52 3.0 66 50
4. Pr2g/24hr+ 19 60 10.9 52 4.2 58 58
5. C/Cr< 35 Pr < 2g 7 62 14.6 25 0.8 100 71
6. C/Cr 50+ Pr 2g+ 8 55 9.7 75 4.9 50 25
The TO shows adequate C, with a mean of 61.5 37 (range 13 to 153).
Fifteen patients had a C. less than 35 mI/mm. The mean Pr was 2.5 g/24
hr (range, 0.24 to 6.8) and ten patients excreted more than 4 g/24 hr. The
JR with a longer DUR of disease than the O/D (P < 0.02) had less Pr (P
< 0.02) and a higher Ccr. Subgroup 5 with a low Cc. had minimal
proteinuria. Subgroup 6 was younger with heavy proteinuria yet well
preserved Ccr. Deaths due to uremia were rare. DUR of diabetes did
not correlate with renal status. The IR group had better renal function
than the O/D group. In marked contrast to JOD we have shown:
subgroup 5 with a low C. yet minimal Pr and VAS/D prominent; while
subgroup 6 had a well preserved C. yet heavy proteinuria.
Membranous glomerulonephritis in black children—association with
hepatitis B antigenemia. J. Seggie, K. Naidoo, and P. G. Davies.
Department of Medicine, University of the Witwatersrand, Johan-
nesburg, South Africa. In a survey of the nephrotic syndrome (NS)
among black Zimbabwean children 8 of 23 (35%) proved to have
membranous glomerulonephritis (GN) which was invariably associated
with carriage of the hepatitis B surface antigen (HB5Ag).
Microhematuria, hypertension, and mild-to-moderate renal insuffi-
ciency were frequent early associated findings and every child exhibited
hypocomplementemia and a markedly diminished immunoglobulin G
(IgG) level. Four children were treated with high-dose alternate day
corticosteroids without demonstrable benefit; spontaneous remission
occurred in seven children 8 to 12 months after presentation, while one
child died in renal failure. An attempt to prove an etiological role for the
HB virus by demonstrating presence of the HB5Ag in biopsy specimens
was unsuccessful. Nevertheless, the absolute consistency of the as-
sociation of HBs antigenemia and membranous GN in the eight children
studied, viewed against the background of 5% carrier rate in healthy
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children, strongly suggests an important role for the HB virus in the
genesis of childhood nephrosis in Zimbabwe.
The frequency of HBsAg in membranous nephropathy and mesangi-
ocapillary glomerulonephritis in black and white South African patients.
L. Dreyer. Department of Anatomical Pathology, University of
Pretoria and H. F. Verwoerd Hospital, Pretoria, South Africa. A study
of 324 renal biopsy specimens included 28 patients with membranous
nephropathy (MN) and 54 patients with mesangiocapillary glomerulo-
nephritis (MCGN). There were 17 black (10%) and 10 white (6.8%)
patients with MN. MCGN occurred in 34 black (20%) and 20 white
(13.4%) patients. The high frequency of both types of glomerulo-
nephritis in the black population is probably related to the known high
carrier rate of hepatitis B-virus (HBV) in this population group (7 to
10%). The renal biopsy specimens were investigated for deposits
containing HBsAg, using the peroxidase antiperoxidase method. Four-
teen of the 15 (97%) biopsy specimens from black patients and two of
the eight (25%) biopsy specimens from white patients with MN which
were investigated were positive. In the MCGN group 11 of the 27(41%)
black patients and 2 of the 14 (14%) white patients were positive.
HBsAg appears to be the most important antigen in MN in black
patients and it also plays an important role in the pathogenesis of
MCGN in some black patients.
Atenolol and slow release nifedipine as initial therapy in blacks with
malignant hypertension. C. G. Isles, A. 0. C. Johnson, and F. J. Mime.
Department of Medicine, Hillbrow Hospital, Johannesburg, South
Africa. Since precipitous falls in blood pressure (BP) in patients
presenting with malignant hypertension (MHT) may lead to neurologi-
cal complications, initial treatment with one drug given orally has been
recommended. Ten patients with grade 3 or 4 retinopathy whose
diastolic blood pressure (DBP) remained greater than 120 after 3 hr bed
rest were entered into the study. Five were given Atenolol 100mg orally
at 0 hr, five received slow release Nifedipine 40 mg orally at 0 hr and
again at 12 hr. BP was measured using a semi-automated recorder
(Omega 1000) at 15-mm intervals from —3 to 24 hr. Patients remained
supine throughout. BP fell in all patients; the absolute fall in systolic
blood pressure (SBP) and DBP was significant at P < 0.01 after the first
hour. The maximum fall in mean arterial pressure (MAP) with Atenolol
occurred at 17 hr while that of Nifedipine occurred 5 hr after each dose.
Although the effects of Nifedipine began to wear off after 5 hr the
differences between the two groups were not significant at any time
(table). Heart rate slowed after Atenolol and increased after Nifedipine.
One patient in the Nifedipine group complained of headache. No other
side effects were reported. The table below shows SBP and DBP (+ sE)
after Atenolol (A) and Nifedipine (N).
Time
(hr) 0 1 5 12 13 17 24
A 229(5)
144(4)
208(6)
128(7)
180(7)
107(3)
172(10) 166(12)
107(5) 102(7)
159(9)
100(3)
169(8)
104(9)
N 231(4)
143(5)
200(16)
122(12)
168(7)
100(8)
178(10) 177(12)
111(6) 111(8)
158(9)
94(8)
180(8)
113(10)
Despite their different mechanisms of action, both Atenolol and slow
release Nifedipine appear effective in black patients with MHT.
Tissue typing and anti-endothelial antibodies (EAb) in blacks with
malignant hypertension (MHT). A. 0. C. Johnson, C. G. Isles, A. M.
Meyers, E. du Toit, J. A. Smit, J. H. Stark, D. Taljaard, and J. A.
Myburgh. University of Witwatersrand and Provincial Tissue Immunol-
ogy Laboratory, Cape Town, South Africa. Black South Africans have
a higher incidence of MHT Ihan white Africans. A higher frequency in
black than white patients of HLA-DRw6 and its postulated association
with EAb, suggests an association of MHT, DRw6 and EAb. This may
in turn explain the poor outcome of renal transplantation in black
patients with MHT. Twenty-eight black patients with MHT (grade 3 or
4 retinopathy) were tissue-typed at A, B, C, and DR loci and their
results were compared with 29 black patients having non-MHT,
matched as far as possible for BP before treatment, and a further group
of 101 healthy, normotensive black patients. An indirect im-
munofluorescent antibody (IFA) test directed against endothelial cells
derived from human umbilical cord veins was used to screen for EAb in
the MHT sera. In descending order of frequency the commonest HLAs
found in patients with MHT were DR3 50%, B15B 44%, Cw2 43%, Cw6
43%, DR5 42% which compare with non-MHT values of 39%, 27%,
41%, 14% and 31%, respectively. A similar frequency of DRw6 was
found in MHT (3 1%) and non-MHT (38%) but both were raised when
compared to normotensive patients (24%). Preliminary results of the
IFA suggest possible EAb in 3 out of 28 MHT patients only. No
statistically significant differences in HLA frequency have emerged in
this study although numbers remain small. A larger study group may
reveal further information. DRw6 does not appear to differentiate MHT
from non-MHT but may be associated with hypertension per se. EAb
formation was not strongly associated with the development of MHT in
these patients.
Magnesium, calcium, sodium, and potassium status in normotensive
and hypertensive Johannesburg black patients. R. M. Touyz. Depart-
ment of Medicine, University of the Witwatersrand, Johannesburg,
South Africa. Although the association between hypomagnesemia and
hypertension has been reported in experimental animals, studies exam-
irling the relationship between magnesium and blood pressure (BP) in
humans are rare. The aim of this paper is to report the findings of a
study which investigated serum (S) and red blood cell (RBC) concentra-
tions of magnesium (Mg ), sodium (Nat), potassium (K), and
serum calcium (Cat +) concentrations in normotensive and hyper-
tensive Johannesburg black males. The ions were measured by atomic
absorption spectroscopy and standard flame photometry, and the
results were checked by the SAIMR autoanalyzer. Two hundred
normotensive (mean systolic pressure, 126.19 8.70; mean diastolic,
73.68 8.31) and 100 hypertensive patients (mean systolic, BP 151.10
16.76; mean diastolic, BP 100.74 11.07) were studied and there
were no significant differences in height and weight between the two
groups.
Mgil (S) Mg (RBC) Ca + (S)
NT N = 200
HT N = 100
0.94
0.82
0.08 2.29 0.50
0.07 1.91 0.52
2.42 0.25
2.25 0.24
Na (RBC) K (S)
NT N = 200
HT N = 100
6.99 1.96
8.49 2.63
3.86 0.34
3.74 0.38
The results (mean 1 SD, concentrations in mmoles/liter) indicate that
serum Mg , Ca K and RBC Mg + levels were significantly
lower in hypertensive patients than in normotensives (P < 0.025) and
that RBC Na was significantly higher in the hypertensive group (P <
0.025). There was no significant difference in serum Na and RBC K
between the two groups. Thus, Mg * and Ca * may play an important
role in the control of BP.
Potassium supplementation in black patients attending a nondrug
hypertension clinic. S. M. Matlou, C. G. Isles, A. Higgs, I. F. Starke, F.
J. Mime, and E. Schultz. Hypertension Clinic, Hillbrow Hospital,
Johannesburg, South Africa. In view of recent work showing that
potassium (K) supplementation lowers blood pressure (BP) in white
subjects, we compared the addition of potassium chloride (KCI) salt and
placebo in black female domestic servants with mild-to-moderate
essential hypertension attending the nondrug hypertension clinic. Pa-
tients were seen at 2-week intervals throughout the study which began
with a 6-week run in period on placebo. Those with DBP 90 mm Hg
at each run in visit then entered a single blind randomized crossover
comparison of 6 weeks (KCI 65 mmoles/day) and 6 weeks placebo
without alteration of dietary Na or K intake. BP was measured in
triplicate by a single observer using an Astropulse recorder which has a
digital display to eliminate observer bias. Thirty-five patients entered
the randomization phase and 32 completed the study. Three defaulted
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and have been excluded from the analysis. Compared with placebo,
KCI salt was associated with significant rises in serum and urine K and
a small fall in SBP and DBP which was significant for SBP at 6 weeks
(P < 0.05) (see table showing means SE for BP, wt, urine, and serum
electrolytes). These differences were not influenced by the order of
randomization.
Treat-
ment
phase
(6th
wk)
SBP DBP
- —
mm Hg
Wt
kg
UK UNa
mmoles/ 24 hr
Serum
K
mmoles/
liter
Placebo
KCI
151(3) 103(2)
144(3) 100(2)
72(2)
72(2)
52(3) 130 (9)
114(8) 165(13)
3.9(0.1)
4.3(0.1)
A mean fall in BP of 7/3 mm Hg would, if maintained, reduce the need
for drug therapy in patients with mild essential hypertension. KCI salt
appears to be as effective as slow K and is certainly a less expensive
way of achieving this result.
Mortality attributable to hypertension in South African black and white
patients. C. G. Isles, L. D. Saunders, and E. Schultz. Department of
Medicine, University of the Witwatersrand, Johannesburg, South Af-
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rica. The prevalence of hypertension among urban blacks in South
Africa (SA) is now known to be at least as high as that recorded in urban
whites. It is generally believed, however, that the vascular complica-
tions of hypertension experienced by blacks (hemorrhagic stroke, heart
failure, and uremia) differ from those occurring in whites (myocardial
infarction and thrombotic stroke). In this study we have attempted to
determine the patterns of disease attributable to hypertension in SA
blacks and whites in 1970 by calculating age- and sex-related mortality
due to diseases of the circulatory system. At each decile of age black
males (BM) had lower mortality rates for circulatory diseases than
white males (WM), whereas black females (BF) experienced a higher
mortality rate than both white females (WF) and BM. This is a reversal
of the pattern seen in whites and may reflect the greater prevalence of
hypertension in the urban black female. Further analysis of male
circulatory deaths showed that the cause of death among WM was due
to their very high prevalence of ischemic heart disease (IHD). IHD was
18 times more common in WM aged 45 to 54 years. By contrast deaths
due to cerebrovascular disease and to hypertensive disease were two
and four times more common, respectively, in BM. Although consider-
able doubt has been expressed concerning the reliability of mortality
statistics in blacks, these figures are supported by autopsy findings in
black patients dying in Johannesburg. The most striking finding in this
study is the continuing low prevalence of IHD among urban blacks,
which may not be explained entirely by known risk factors.
